Health for Small businesses Grants

This funding opportunity provides financial support for small businesses to develop innovative e-learning training products that enhance the safety and health training of workers dealing with hazardous materials and emergency response situations.

This funding opportunity provides financial support to small businesses in the U.S. that are developing innovative health-related products and need assistance with late-stage research, clinical trials, and commercialization efforts after receiving prior NIH funding.

This funding opportunity provides financial support to organizations that help low-income older adults in New York maintain their independence and safety at home through health services and home modifications.

This funding opportunity provides financial support for training and professional development of individuals from underrepresented backgrounds in health-related research, including students and researchers at various career stages.

This funding opportunity supports small businesses in developing innovative informatics tools that facilitate the use of the human pangenome reference for research and clinical applications in genomics.

This funding opportunity supports small businesses in developing innovative informatics tools that enhance the use and accessibility of the human pangenome reference for genomic research and clinical applications.

This funding opportunity provides financial support to organizations that will establish training centers and support hubs to improve the skills and job flexibility of direct care workers in New York, addressing the growing demand for Personal Care Aides, Home Health Aides, and Certified Nursing Assistants.

This funding opportunity is designed to support small businesses in developing new medications for treating alcohol use disorder and related organ damage, helping them advance their therapeutic candidates toward FDA approval.

This funding opportunity is designed to support small businesses in developing innovative medications for treating alcohol use disorder and related organ damage, helping them advance their drug candidates toward FDA approval.

This funding opportunity supports small businesses developing innovative technologies for rare diseases and pediatric populations, helping them bridge the gap between research and commercialization.

This grant provides funding to small U.S.-based businesses developing innovative technologies for heart, lung, blood, and sleep disorders, helping them bridge the gap between research and market readiness.

This funding opportunity provides financial support to small businesses in the U.S. for conducting exploratory clinical trials or biomarker validation studies aimed at advancing therapies for neurological disorders.

This funding opportunity provides financial support to local organizations in Wake County, North Carolina, to promote health literacy and equity among historically marginalized communities through various health education initiatives and outreach programs.

This funding opportunity supports small businesses in developing innovative technologies and services for population-wide genomic screening to improve primary care for common genetic conditions.

This funding opportunity supports small U.S.-based businesses in developing innovative solutions for population genomic screening to improve primary care practices and enhance patient outcomes.

Some projects initiated with SBIR or STTR funding require considerable financing beyond the SBIR/STTR Phase II award to achieve commercialization. The development of medical biotechnology products is often impeded by a significant funding gap (known as the Valley of Death) between the end of the SBIR/STTR Phase II award and the commercialization stage. The goal of this FOA is to assist applicants in pursuing the next appropriate milestone(s) necessary to advance a product/technology that requires Federal regulatory approval or to bring a complex research tool to market. This opportunity aims to facilitate the transition of previously funded SBIR and STTR Phase II projects to the commercialization stage by promoting partnerships between NINDS SBIR or STTR awardees and third-party investors and/or strategic partners in the Phase IIB competing renewal. Applicants are strongly encouraged to secure independent third-party funding throughout the Phase IIB project period.

This funding opportunity supports U.S.-based small businesses in developing innovative clinical diagnostic tools that address health disparities and improve healthcare access for diverse populations.

This funding opportunity supports U.S.-based small businesses in developing innovative diagnostic tools to reduce health disparities among diverse patient populations.

This funding opportunity provides financial support for small businesses to conduct innovative clinical trials related to allergy and infectious diseases, focusing on high-risk studies and unlicensed products.

This funding opportunity provides financial support to small U.S.-based businesses for the development and validation of analytical methods to measure biomarkers related to neurological and neuromuscular disorders, with an emphasis on enhancing inclusivity and collaboration in research.